With the analysis of cancer metabolism and genetics over the past two decades, IDH1 mutations not only lead to the accumulation of 2-hydroxyglutaric acid, but also to extensive changes in metabolic strategies, and metabolic reprogramming can be largely seen as a result of oncogenic driving events (38). Here, IDH1 is linked to cancer.